Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis

Georgie J. MacArthur, Silvia Minozzi, Natasha Martin, Peter Vickerman, Sherry Deren, Julie Bruneau, Louisa Degenhardt, Matthew Hickman

Research output: Contribution to journalArticle

Abstract

Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data sources: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. Review methods: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. Results: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P2=60%, χ2=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. Conclusion: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.

Original languageEnglish (US)
Article numbere5945
JournalBritish Medical Journal
Volume345
Issue number7879
DOIs
StatePublished - Oct 20 2012

Fingerprint

Opiate Substitution Treatment
Meta-Analysis
HIV
Pharmaceutical Preparations
HIV Infections
Risk Reduction Behavior
Motivation
Information Storage and Retrieval
Methadone
Risk-Taking
Libraries
Observational Studies
Cohort Studies
Language
Confidence Intervals

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Opiate substitution treatment and HIV transmission in people who inject drugs : Systematic review and meta-analysis. / MacArthur, Georgie J.; Minozzi, Silvia; Martin, Natasha; Vickerman, Peter; Deren, Sherry; Bruneau, Julie; Degenhardt, Louisa; Hickman, Matthew.

In: British Medical Journal, Vol. 345, No. 7879, e5945, 20.10.2012.

Research output: Contribution to journalArticle

MacArthur, GJ, Minozzi, S, Martin, N, Vickerman, P, Deren, S, Bruneau, J, Degenhardt, L & Hickman, M 2012, 'Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis', British Medical Journal, vol. 345, no. 7879, e5945. https://doi.org/10.1136/bmj.e5945
MacArthur, Georgie J. ; Minozzi, Silvia ; Martin, Natasha ; Vickerman, Peter ; Deren, Sherry ; Bruneau, Julie ; Degenhardt, Louisa ; Hickman, Matthew. / Opiate substitution treatment and HIV transmission in people who inject drugs : Systematic review and meta-analysis. In: British Medical Journal. 2012 ; Vol. 345, No. 7879.
@article{f274f39f70c14655b457b96ea2efd2c8,
title = "Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis",
abstract = "Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data sources: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. Review methods: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. Results: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54{\%} reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95{\%} confidence interval 0.32 to 0.67; P2=60{\%}, χ2=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. Conclusion: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.",
author = "MacArthur, {Georgie J.} and Silvia Minozzi and Natasha Martin and Peter Vickerman and Sherry Deren and Julie Bruneau and Louisa Degenhardt and Matthew Hickman",
year = "2012",
month = "10",
day = "20",
doi = "10.1136/bmj.e5945",
language = "English (US)",
volume = "345",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7879",

}

TY - JOUR

T1 - Opiate substitution treatment and HIV transmission in people who inject drugs

T2 - Systematic review and meta-analysis

AU - MacArthur, Georgie J.

AU - Minozzi, Silvia

AU - Martin, Natasha

AU - Vickerman, Peter

AU - Deren, Sherry

AU - Bruneau, Julie

AU - Degenhardt, Louisa

AU - Hickman, Matthew

PY - 2012/10/20

Y1 - 2012/10/20

N2 - Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data sources: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. Review methods: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. Results: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P2=60%, χ2=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. Conclusion: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.

AB - Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data sources: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. Review methods: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. Results: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P2=60%, χ2=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. Conclusion: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.

UR - http://www.scopus.com/inward/record.url?scp=84867761204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867761204&partnerID=8YFLogxK

U2 - 10.1136/bmj.e5945

DO - 10.1136/bmj.e5945

M3 - Article

VL - 345

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

IS - 7879

M1 - e5945

ER -